These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 20937311

  • 1. Mycobacterial cell-wall skeleton as a universal vaccine vehicle for antigen conjugation.
    Paik TH, Lee JS, Kim KH, Yang CS, Jo EK, Song CH.
    Vaccine; 2010 Nov 23; 28(50):7873-80. PubMed ID: 20937311
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant activity of mycobacterial fractions. I. Purification and in vivo adjuvant activity of cell wall skeletons of Mycobacterium bovis BCG, Nocardia asteroides 131 and Corynebacterium diphtheriae PW8.
    Azuma I, Kanetsuna F, Taniyama T, Yamamura Y, Hori M.
    Biken J; 1975 Mar 23; 18(1):1-13. PubMed ID: 807194
    [Abstract] [Full Text] [Related]

  • 3. Improved immunogenicity of recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing fusion protein Ag85A-ESAT-6 of Mycobacterium tuberculosis.
    Deng YH, Sun Z, Yang XL, Bao L.
    Scand J Immunol; 2010 Oct 23; 72(4):332-8. PubMed ID: 20883318
    [Abstract] [Full Text] [Related]

  • 4. Gene-inducing program of human dendritic cells in response to BCG cell-wall skeleton (CWS), which reflects adjuvancy required for tumor immunotherapy.
    Ishii K, Kurita-Taniguchi M, Aoki M, Kimura T, Kashiwazaki Y, Matsumoto M, Seya T.
    Immunol Lett; 2005 May 15; 98(2):280-90. PubMed ID: 15860229
    [Abstract] [Full Text] [Related]

  • 5. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses.
    Trujillo-Vargas CM, Mayer KD, Bickert T, Palmetshofer A, Grunewald S, Ramirez-Pineda JR, Polte T, Hansen G, Wohlleben G, Erb KJ.
    Clin Exp Allergy; 2005 Aug 15; 35(8):1003-13. PubMed ID: 16120081
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The liposome-incorporating cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guéin can directly enhance the susceptibility of cancer cells to lymphokine-activated killer cells through up-regulation of natural-killer group 2, member D ligands.
    Miyazaki J, Kawai K, Kojima T, Oikawa T, Joraku A, Shimazui T, Nakaya A, Yano I, Nakamura T, Harashima H, Akaza H.
    BJU Int; 2011 Nov 15; 108(9):1520-6. PubMed ID: 21314815
    [Abstract] [Full Text] [Related]

  • 12. CpG-DNA stimulates cellular and humoral immunity and promotes Th1 differentiation in aged BALB/c mice.
    Maletto B, Rópolo A, Morón V, Pistoresi-Palencia MC.
    J Leukoc Biol; 2002 Sep 15; 72(3):447-54. PubMed ID: 12223511
    [Abstract] [Full Text] [Related]

  • 13. Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines.
    Aldovini A, Young RA.
    Nature; 1991 Jun 06; 351(6326):479-82. PubMed ID: 2046750
    [Abstract] [Full Text] [Related]

  • 14. Immunization with heat-killed Mycobacterium bovis bacille Calmette-Guerin (BCG) in Eurocine L3 adjuvant protects against tuberculosis.
    Haile M, Schröder U, Hamasur B, Pawlowski A, Jaxmar T, Källenius G, Svenson SB.
    Vaccine; 2004 Mar 29; 22(11-12):1498-508. PubMed ID: 15063575
    [Abstract] [Full Text] [Related]

  • 15. Immunomodulatory activity of novel adjuvant formulations based on Montanide ISA oil-based adjuvants and peptidoglycan monomer.
    Habjanec L, Halassy B, Tomasić J.
    Int Immunopharmacol; 2008 May 29; 8(5):717-24. PubMed ID: 18387514
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation.
    Udagawa M, Kudo-Saito C, Hasegawa G, Yano K, Yamamoto A, Yaguchi M, Toda M, Azuma I, Iwai T, Kawakami Y.
    Clin Cancer Res; 2006 Dec 15; 12(24):7465-75. PubMed ID: 17189420
    [Abstract] [Full Text] [Related]

  • 17. Evidence for enhanced central memory priming by live Mycobacterium bovis BCG vaccine in comparison with killed BCG formulations.
    Whelan AO, Wright DC, Chambers MA, Singh M, Hewinson RG, Vordermeier HM.
    Vaccine; 2008 Jan 10; 26(2):166-73. PubMed ID: 18055073
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of bovine cutaneous delayed-type hypersensitivity (DTH) to various test antigens and a mitogen using several adjuvants.
    Hernández A, Yager JA, Wilkie BN, Leslie KE, Mallard BA.
    Vet Immunol Immunopathol; 2005 Mar 10; 104(1-2):45-58. PubMed ID: 15661330
    [Abstract] [Full Text] [Related]

  • 19. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice.
    Mallat Z, Gojova A, Brun V, Esposito B, Fournier N, Cottrez F, Tedgui A, Groux H.
    Circulation; 2003 Sep 09; 108(10):1232-7. PubMed ID: 12912803
    [Abstract] [Full Text] [Related]

  • 20. Optimization of cell-wall skeleton derived from Mycobacterium bovis BCG Tokyo 172 (SMP-105) emulsion in delayed-type hypersensitivity and antitumor models.
    Miyauchi M, Murata M, Fukushima A, Sato T, Nakagawa M, Fujii T, Koseki N, Chiba N, Kashiwazaki Y.
    Drug Discov Ther; 2012 Aug 09; 6(4):218-25. PubMed ID: 23006993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.